AIMS: Sudden arrhythmogenic cardiac death is a major cause of mortality in patients with congestive heart failure (CHF). To investigate determinants of the increased arrhythmogenic susceptibility, we studied cardiac remodelling and arrhythmogenicity in CHF patients and in a mouse model of chronic pressure overload. METHODS AND RESULTS: Clinical and (immuno)histological data of myocardial biopsies from CHF patients with (VT+) and without (VT-) documented ventricular arrhythmia were compared with controls. In CHF patients, ejection fraction was decreased and QRS duration was increased. Cell size and interstitial fibrosis were increased, but Connexin43 (Cx43) levels, the most abundant gap junction in ventricular myocardium, were unchanged. No differences were found between VT+ and VT- patients, except for the distribution pattern of Cx43, which was significantly more heterogeneous in VT+. Mice were subjected to transverse aortic constriction (TAC) or sham operated. At 16 weeks, cardiac function was determined by echocardiography and epicardial ventricular activation mapping was performed. Transverse aortic constriction mice had decreased fractional shortening and prolonged QRS duration. Right ventricular conduction velocity was reduced, and polymorphic VTs were induced in 44% TAC and 0% sham mice. Interstitial fibrosis was increased and Cx43 quantity was unchanged in TAC mice with and without arrhythmias. Similar to CHF patients, heterogeneous Cx43 distribution was significantly associated with arrhythmias in TAC mice and with spatial heterogeneity of impulse conduction. CONCLUSION: Heterogeneous Cx43 expression during CHF is associated with dispersed impulse conduction and may underlie enhanced susceptibility to ventricular tachyarrhythmias.
AIMS: Sudden arrhythmogenic cardiac death is a major cause of mortality in patients with congestive heart failure (CHF). To investigate determinants of the increased arrhythmogenic susceptibility, we studied cardiac remodelling and arrhythmogenicity in CHFpatients and in a mouse model of chronic pressure overload. METHODS AND RESULTS: Clinical and (immuno)histological data of myocardial biopsies from CHFpatients with (VT+) and without (VT-) documented ventricular arrhythmia were compared with controls. In CHFpatients, ejection fraction was decreased and QRS duration was increased. Cell size and interstitial fibrosis were increased, but Connexin43 (Cx43) levels, the most abundant gap junction in ventricular myocardium, were unchanged. No differences were found between VT+ and VT- patients, except for the distribution pattern of Cx43, which was significantly more heterogeneous in VT+. Mice were subjected to transverse aortic constriction (TAC) or sham operated. At 16 weeks, cardiac function was determined by echocardiography and epicardial ventricular activation mapping was performed. Transverse aortic constriction mice had decreased fractional shortening and prolonged QRS duration. Right ventricular conduction velocity was reduced, and polymorphic VTs were induced in 44% TAC and 0% sham mice. Interstitial fibrosis was increased and Cx43 quantity was unchanged in TAC mice with and without arrhythmias. Similar to CHFpatients, heterogeneous Cx43 distribution was significantly associated with arrhythmias in TAC mice and with spatial heterogeneity of impulse conduction. CONCLUSION: Heterogeneous Cx43 expression during CHF is associated with dispersed impulse conduction and may underlie enhanced susceptibility to ventricular tachyarrhythmias.
Authors: M Boulaksil; M Noorman; M A Engelen; T A B van Veen; M A Vos; J M T de Bakker; H V M van Rijen Journal: Neth Heart J Date: 2010-10 Impact factor: 2.380
Authors: Hiroki Takanari; Vincent J A Bourgonje; Magda S C Fontes; Antonia J A Raaijmakers; Helen Driessen; John A Jansen; Roel van der Nagel; Bart Kok; Leonie van Stuijvenberg; Mohamed Boulaksil; Yoshio Takemoto; Masatoshi Yamazaki; Yukiomi Tsuji; Haruo Honjo; Kaichiro Kamiya; Itsuo Kodama; Mark E Anderson; Marcel A G van der Heyden; Harold V M van Rijen; Toon A B van Veen; Marc A Vos Journal: Cardiovasc Res Date: 2016-06-29 Impact factor: 10.787
Authors: John A Jansen; Maartje Noorman; Hassan Musa; Mèra Stein; Sanne de Jong; Roel van der Nagel; Thomas J Hund; Peter J Mohler; Marc A Vos; Toon A van Veen; Jacques M de Bakker; Mario Delmar; Harold V van Rijen Journal: Heart Rhythm Date: 2011-11-16 Impact factor: 6.343
Authors: Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert Journal: Pharmacol Ther Date: 2015-06-11 Impact factor: 12.310
Authors: Philippe Beauchamp; Thomas Desplantez; Megan L McCain; Weihui Li; Angeliki Asimaki; Ghislaine Rigoli; Kevin Kit Parker; Jeffrey E Saffitz; Andre G Kleber Journal: Circ Res Date: 2012-04-19 Impact factor: 17.367
Authors: Magda S C Fontes; Diana A Papazova; Arianne van Koppen; Sanne de Jong; Sanne M Korte; Lennart G Bongartz; Tri Q Nguyen; Marti F A Bierhuizen; Teun P de Boer; Toon A B van Veen; Marianne C Verhaar; Jaap A Joles; Harold V M van Rijen Journal: Cardiorenal Med Date: 2015-06-05 Impact factor: 2.041
Authors: Maartje Noorman; Sara Hakim; Elise Kessler; Judith A Groeneweg; Moniek G P J Cox; Angeliki Asimaki; Harold V M van Rijen; Leonie van Stuijvenberg; Halina Chkourko; Marcel A G van der Heyden; Marc A Vos; Nicolaas de Jonge; Jasper J van der Smagt; Dennis Dooijes; Aryan Vink; Roel A de Weger; Andras Varro; Jacques M T de Bakker; Jeffrey E Saffitz; Thomas J Hund; Peter J Mohler; Mario Delmar; Richard N W Hauer; Toon A B van Veen Journal: Heart Rhythm Date: 2012-11-23 Impact factor: 6.343
Authors: Karl Toischer; Nico Hartmann; Stefan Wagner; Thomas H Fischer; Jonas Herting; Bernhard C Danner; Can M Sag; Thomas J Hund; Peter J Mohler; Luiz Belardinelli; Gerd Hasenfuss; Lars S Maier; Samuel Sossalla Journal: J Mol Cell Cardiol Date: 2013-04-06 Impact factor: 5.000